Joy Artin, Yumn A. Elsabagh, Laila Rashed, and Mohamed A. Hussein. “Proprotein Convertase Subtilisin Kexin 9 (PCSK9) in Patients With Diffuse Systemic Sclerosis: A Marker of Disease Activity and Severe Disease Manifestations With Potential Therapeutic Implementations”. Archives of Rheumatology 38, no. 2 (June 30, 2023): 249–256. Accessed October 3, 2025. http://anadolupsikiyatri.net/index.php/pub/article/view/1337.